Jenna Bouassaly

McGill University

Papers

1

Total Citations

5

H-Index

1

About

Dr. Jenna Bouassaly is a rising leader in head and neck oncology, whose work is reshaping treatment paradigms for HPV-positive cancers. Her primary research focuses on de-escalation strategies and neoadjuvant therapy, aiming to reduce treatment toxicity while preserving excellent oncologic outcomes. Her most-cited paper, "Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer" (2024, 5 citations), offers a critical synthesis of emerging clinical trials and challenges the conventional one-size-fits-all approach. By advocating for risk-adapted protocols, Dr. Bouassaly is helping to define a new standard of care that prioritizes quality of life without compromising survival. Her work has already garnered attention for its clarity and clinical relevance, positioning her as a key voice in the next generation of head and neck cancer researchers. For students and clinicians alike, Dr. Bouassaly’s research provides a forward-looking roadmap for personalizing therapy in an era of precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: McGill University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago